Goldman Sachs
TPST icon

Goldman Sachs’s Tempest Therapeutics TPST Stock Holding History

Goldman Sachs’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-107
Closed -$25K – 6520
2021
Q1 		$25K Sell
107
-111
-51% -$44.9K ﹤0.01% 6000
2020
Q4 		$91K Sell
218
-192
-47% -$66.4K ﹤0.01% 5306
2020
Q3 		$130K Sell
410
-13
-3% -$4.41K ﹤0.01% 5032
2020
Q2 		$145K Buy
423
+329
+350% +$131K ﹤0.01% 4896
2020
Q1 		$97K Buy
+94
New +$137K ﹤0.01% 4946
2019
Q2 		– Sell
-73
Closed -$215K – 5349
2019
Q1 		$215K Buy
+73
New +$161K ﹤0.01% 4766
2018
Q1 		– Sell
-24
Closed -$97K – 6395
2017
Q4 		$97K Buy
+24
New +$101K ﹤0.01% 5756
2017
Q3 		– Sell
-28
Closed -$129K – 6862
2017
Q2 		$129K Buy
+28
New +$118K ﹤0.01% 6022
2017
Q1 		– Sell
-27
Closed -$121K – 7005
2016
Q4 		$121K Buy
27
+20
+286% +$249K ﹤0.01% 6050
2016
Q3 		$145K Buy
7
+3
+75% +$54.3K ﹤0.01% 6026
2016
Q2 		$64K Sell
4
-7
-64% -$160K ﹤0.01% 6325
2016
Q1 		$294K Sell
11
-111
-91% -$2.35M ﹤0.01% 5284
2015
Q4 		$3.48M Buy
122
+96
+369% +$3.17M ﹤0.01% 3157
2015
Q3 		$643K Buy
26
+17
+189% +$1.14M ﹤0.01% 4896
2015
Q2 		$762K Buy
9
+5
+125% +$458K ﹤0.01% 4787
2015
Q1 		$436K Buy
4
+2
+100% +$266K ﹤0.01% 5274
2014
Q4 		$260K Buy
+2
New +$146K ﹤0.01% 5928

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs's TPST Position: Q2 2021 in Review

Goldman Sachs sold out of Tempest Therapeutics (TPST) in Q2 2021, closing a stake of 107 shares — an estimated $25K sold.

Goldman Sachs first reported a position in TPST in Q4 2014 and held it in 17 quarters. The position peaked at $3.48M in Q4 2015. 23 funds tracked by Wall St. Rank hold TPST as of Q2 2021.

  • Goldman Sachs reported no remaining Tempest Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 107 Tempest Therapeutics shares in Q2 2021, an estimated $25K.
  • Goldman Sachs first reported a position in Tempest Therapeutics in Q4 2014 and held it in 17 quarters.
  • Goldman Sachs's Tempest Therapeutics position peaked at $3.48M in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.